Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 6—June 2010
Dispatch

Enterovirus Genotype EV-104 in Humans, Italy, 2008–2009

Antonio Piralla, Francesca Rovida, Fausto Baldanti, and Giuseppe GernaComments to Author 
Author affiliations: Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Policlinico, San Matteo, Pavia, Italy

Main Article

Figure 2

Virologic and clinical follow-up of immunocompromised patient infected with Pavia strain (Pav-5) showing the kinetics of enterovirus 104 (EV-104) and respiratory syncytial virus (RSV) viral loads, along with respiratory symptoms. Starting on day 90 after transplantation, the patient’s clinical symptoms began to disappear in the presence of a substantially unchanged EV-104 viral load in respiratory secretions. Ct, cycle threshold; HSC, hematopoietic stem cells.

Figure 2. Virologic and clinical follow-up of immunocompromised patient infected with Pavia strain (Pav-5) showing the kinetics of enterovirus 104 (EV-104) and respiratory syncytial virus (RSV) viral loads, along with respiratory symptoms. Starting on day 90 after transplantation, the patient’s clinical symptoms began to disappear in the presence of a substantially unchanged EV-104 viral load in respiratory secretions. Ct, cycle threshold; HSC, hematopoietic stem cells.

Main Article

Page created: February 10, 2011
Page updated: February 10, 2011
Page reviewed: February 10, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external